About ALSI Pharma
ALSI Pharma was founded in 2000 and is headquartered in Moscow, Russia. Operations are centered in the upstream energy sector, with a primary emphasis on natural gas resources in the North Sea. Exploration, appraisal, development, and production activities are conducted across the upstream value chain. Existing production assets are maintained alongside projects under development. International projects have been undertaken, though North Sea operations remain the core focus.
- Headquarter Moscow, Russia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Xantis Pharma
(Sep 20, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ALSI Pharma
Detailed funding history for ALSI Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ALSI Pharma
ALSI Pharma has secured backing from 1 investor. Prominent investors backing the company include Xantis Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Distributor of generic prescription and over-the-counter products
|
Locked | Locked | Locked |
Investor details for ALSI Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ALSI Pharma
Investment portfolio details for ALSI Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ALSI Pharma
Detailed financials for ALSI Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alsi Pharma Comparisons
Peer comparison for ALSI Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ALSI Pharma
Detailed competitors of ALSI Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alsi Pharma
Complete news archive for ALSI Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ALSI Pharma
ALSI Pharma was founded in 2000.
ALSI Pharma is headquartered in Moscow, Russia.
ALSI Pharma was founded in 2000 and is headquartered in Moscow, Russia. Operations are centered in the upstream energy sector, with a primary emphasis on natural gas resources in the North Sea. Exploration, appraisal, development, and production activities are conducted across the upstream value chain. Existing production assets are maintained alongside projects under development. International projects have been undertaken, though North Sea operations remain the core focus.
ALSI Pharma has 1 investor. Key investors include Xantis Pharma.